testimonials
"IORT parameters can be defined the day before to the treatment 90% of the times", "the system enhances the capabilities of documentation of the process for posterior analysis", Prof. Felipe Calvo, Oncology Department Director, Gregorio Marañon University Hospital, Madrid.
"It is an important advance in the history of IORT", "The preplanning phase is an important improvement in the IORT treatment of the breast cancer", "Brest surgery can be predicted previously and the different parameters of the treatment can be defined beforehand", Prof. Roberto Orecchia, Radiotherapy Division Director, Istituto Europeo di Oncologia, Milan.
GMV obtains authorization for selling its intraoperative radiation therapy planning system in the USA
01/17/2012
GMV has received official authorization from the USA’s Food and Drug Administration (FDA) to market
...
GMV and Azierta join forces to provide innovation in the technology and health area
12/15/2011
GMV and Azierta have signed a Collaboration Agreement for the creation and implementation of innovating
...
